Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 63 | 2024 | 1292 | 7.200 |
Why?
|
Embryo Transfer | 39 | 2023 | 522 | 4.200 |
Why?
|
Preimplantation Diagnosis | 9 | 2023 | 143 | 3.630 |
Why?
|
Infertility | 17 | 2024 | 655 | 3.330 |
Why?
|
Infertility, Female | 25 | 2024 | 759 | 3.220 |
Why?
|
Oocytes | 26 | 2023 | 1165 | 3.090 |
Why?
|
Reproductive Techniques, Assisted | 17 | 2024 | 497 | 2.950 |
Why?
|
Cryopreservation | 20 | 2023 | 717 | 2.870 |
Why?
|
Public Opinion | 9 | 2019 | 481 | 2.730 |
Why?
|
Pregnancy Rate | 34 | 2023 | 649 | 2.500 |
Why?
|
Oocyte Retrieval | 13 | 2022 | 158 | 2.460 |
Why?
|
Ovulation Induction | 14 | 2023 | 277 | 2.410 |
Why?
|
Live Birth | 13 | 2024 | 512 | 2.260 |
Why?
|
Oocyte Donation | 6 | 2024 | 52 | 2.240 |
Why?
|
Chorionic Gonadotropin | 10 | 2019 | 457 | 2.160 |
Why?
|
Aneuploidy | 10 | 2023 | 551 | 1.880 |
Why?
|
Fertility | 12 | 2023 | 773 | 1.880 |
Why?
|
Abortion, Spontaneous | 12 | 2023 | 530 | 1.820 |
Why?
|
Sperm Injections, Intracytoplasmic | 9 | 2023 | 156 | 1.610 |
Why?
|
Pregnancy | 89 | 2024 | 29749 | 1.470 |
Why?
|
Ovary | 11 | 2020 | 958 | 1.400 |
Why?
|
Pregnancy Outcome | 19 | 2024 | 2907 | 1.250 |
Why?
|
Estradiol | 23 | 2014 | 1932 | 1.250 |
Why?
|
Pregnancy, Ectopic | 6 | 2017 | 143 | 1.200 |
Why?
|
Genetic Testing | 9 | 2023 | 3531 | 1.180 |
Why?
|
Hysteroscopy | 5 | 2024 | 67 | 1.170 |
Why?
|
Embryo, Mammalian | 11 | 2022 | 1674 | 1.160 |
Why?
|
Reproductive Medicine | 3 | 2020 | 100 | 1.160 |
Why?
|
Leuprolide | 4 | 2023 | 315 | 1.150 |
Why?
|
Blastocyst | 9 | 2023 | 433 | 1.110 |
Why?
|
Uterine Diseases | 2 | 2024 | 117 | 1.070 |
Why?
|
Ovarian Hyperstimulation Syndrome | 3 | 2020 | 47 | 1.050 |
Why?
|
Progesterone | 12 | 2018 | 742 | 1.030 |
Why?
|
Gonadotropins | 4 | 2020 | 241 | 1.010 |
Why?
|
Maternal Age | 8 | 2019 | 807 | 1.000 |
Why?
|
Follicle Stimulating Hormone, Human | 2 | 2020 | 25 | 0.980 |
Why?
|
Gynatresia | 1 | 2024 | 11 | 0.940 |
Why?
|
Tissue Preservation | 2 | 2016 | 174 | 0.860 |
Why?
|
Single Embryo Transfer | 2 | 2019 | 29 | 0.810 |
Why?
|
Birth Rate | 4 | 2023 | 168 | 0.780 |
Why?
|
Paternal Age | 1 | 2021 | 87 | 0.750 |
Why?
|
Obesity | 12 | 2023 | 12922 | 0.750 |
Why?
|
Contraceptive Devices, Female | 2 | 2018 | 40 | 0.750 |
Why?
|
Embryo Implantation | 10 | 2023 | 270 | 0.740 |
Why?
|
Female | 165 | 2024 | 391270 | 0.730 |
Why?
|
Luteal Phase | 3 | 2018 | 138 | 0.720 |
Why?
|
Ovarian Follicle | 7 | 2022 | 244 | 0.720 |
Why?
|
Anti-Mullerian Hormone | 5 | 2021 | 407 | 0.680 |
Why?
|
Follicle Stimulating Hormone | 6 | 2012 | 725 | 0.670 |
Why?
|
Surrogate Mothers | 2 | 2018 | 16 | 0.670 |
Why?
|
Personal Autonomy | 2 | 2018 | 302 | 0.650 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2019 | 3986 | 0.650 |
Why?
|
Adult | 111 | 2024 | 219994 | 0.640 |
Why?
|
Pregnancy, Multiple | 6 | 2023 | 215 | 0.630 |
Why?
|
Uterine Hemorrhage | 4 | 2023 | 242 | 0.610 |
Why?
|
Directed Tissue Donation | 1 | 2017 | 18 | 0.580 |
Why?
|
Infant, Small for Gestational Age | 1 | 2020 | 460 | 0.570 |
Why?
|
Insemination, Artificial | 4 | 2011 | 99 | 0.570 |
Why?
|
Intrauterine Devices, Medicated | 1 | 2017 | 26 | 0.560 |
Why?
|
Levonorgestrel | 1 | 2017 | 74 | 0.560 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2017 | 81 | 0.560 |
Why?
|
Compensation and Redress | 1 | 2017 | 66 | 0.550 |
Why?
|
Transsexualism | 1 | 2019 | 177 | 0.530 |
Why?
|
Breast Neoplasms | 20 | 2022 | 21025 | 0.520 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2020 | 377 | 0.520 |
Why?
|
Humans | 169 | 2024 | 760621 | 0.520 |
Why?
|
Endometrial Neoplasms | 2 | 2018 | 1357 | 0.510 |
Why?
|
Tissue Donors | 6 | 2024 | 2313 | 0.510 |
Why?
|
Menstruation Disturbances | 1 | 2016 | 143 | 0.500 |
Why?
|
Endocrinology | 2 | 2013 | 443 | 0.490 |
Why?
|
Carcinoma, Endometrioid | 1 | 2018 | 276 | 0.490 |
Why?
|
Gastroplasty | 1 | 2016 | 157 | 0.480 |
Why?
|
Premenopause | 6 | 2012 | 1038 | 0.470 |
Why?
|
Ideal Body Weight | 1 | 2014 | 27 | 0.460 |
Why?
|
Retrospective Studies | 46 | 2024 | 80372 | 0.460 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2011 | 1529 | 0.450 |
Why?
|
Uterus | 5 | 2018 | 651 | 0.440 |
Why?
|
Insemination, Artificial, Homologous | 1 | 2013 | 17 | 0.440 |
Why?
|
Young Adult | 29 | 2023 | 58741 | 0.440 |
Why?
|
Hysterectomy | 3 | 2018 | 904 | 0.430 |
Why?
|
Posthumous Conception | 1 | 2012 | 11 | 0.420 |
Why?
|
Survivors | 6 | 2014 | 2375 | 0.410 |
Why?
|
Recombinant Proteins | 4 | 2020 | 6538 | 0.410 |
Why?
|
Semen | 4 | 2023 | 346 | 0.410 |
Why?
|
Estrogen Replacement Therapy | 7 | 1999 | 1206 | 0.400 |
Why?
|
Preconception Care | 3 | 2019 | 139 | 0.390 |
Why?
|
Ultrasonography, Prenatal | 5 | 2018 | 1745 | 0.390 |
Why?
|
Methotrexate | 2 | 2017 | 1719 | 0.370 |
Why?
|
Postmenopause | 8 | 2000 | 2509 | 0.360 |
Why?
|
Prolactin | 6 | 2020 | 621 | 0.360 |
Why?
|
Neoplasms | 8 | 2023 | 22072 | 0.340 |
Why?
|
Multiple Birth Offspring | 1 | 2009 | 22 | 0.340 |
Why?
|
Bariatric Surgery | 2 | 2010 | 1005 | 0.330 |
Why?
|
Myometrium | 2 | 2004 | 176 | 0.320 |
Why?
|
Adolescent | 28 | 2023 | 87810 | 0.310 |
Why?
|
Amenorrhea | 4 | 2021 | 480 | 0.310 |
Why?
|
Tamoxifen | 2 | 2011 | 963 | 0.300 |
Why?
|
Primary Ovarian Insufficiency | 2 | 2023 | 105 | 0.300 |
Why?
|
Gastric Bypass | 1 | 2016 | 829 | 0.300 |
Why?
|
Spermatozoa | 4 | 2024 | 631 | 0.300 |
Why?
|
Patient Selection | 2 | 2019 | 4283 | 0.290 |
Why?
|
Vaginal Creams, Foams, and Jellies | 3 | 2018 | 62 | 0.290 |
Why?
|
Body Mass Index | 11 | 2023 | 12914 | 0.290 |
Why?
|
Attitude | 1 | 2012 | 777 | 0.280 |
Why?
|
Insurance Coverage | 1 | 2018 | 1939 | 0.280 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1287 | 0.280 |
Why?
|
Estrone | 3 | 1998 | 232 | 0.280 |
Why?
|
Receptors, LHRH | 1 | 2007 | 158 | 0.280 |
Why?
|
Embryo Culture Techniques | 3 | 2021 | 84 | 0.270 |
Why?
|
Alkylating Agents | 2 | 2023 | 133 | 0.270 |
Why?
|
Antineoplastic Agents | 8 | 2023 | 13630 | 0.270 |
Why?
|
Fertility Agents, Female | 5 | 2011 | 101 | 0.260 |
Why?
|
Tissue Adhesions | 2 | 2024 | 222 | 0.260 |
Why?
|
Mammary Glands, Animal | 5 | 2009 | 271 | 0.260 |
Why?
|
Reproduction | 2 | 2012 | 646 | 0.250 |
Why?
|
Potassium Chloride | 2 | 2004 | 230 | 0.250 |
Why?
|
Pregnancy Trimester, First | 3 | 2018 | 908 | 0.250 |
Why?
|
Ethanol | 3 | 1996 | 1323 | 0.250 |
Why?
|
Germ Cells | 3 | 2024 | 635 | 0.240 |
Why?
|
Pregnancy, Tubal | 1 | 2004 | 15 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3164 | 0.240 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2009 | 1153 | 0.240 |
Why?
|
Linear Models | 4 | 2019 | 5877 | 0.230 |
Why?
|
Electrocoagulation | 1 | 2004 | 152 | 0.230 |
Why?
|
Chorion | 2 | 2018 | 114 | 0.230 |
Why?
|
Age Factors | 11 | 2021 | 18416 | 0.230 |
Why?
|
Trophoblasts | 1 | 2005 | 224 | 0.220 |
Why?
|
Ploidies | 2 | 2021 | 275 | 0.220 |
Why?
|
Male | 43 | 2024 | 359744 | 0.210 |
Why?
|
Health Services Accessibility | 2 | 2018 | 5397 | 0.210 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3388 | 0.210 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5649 | 0.210 |
Why?
|
Oogenesis | 1 | 2022 | 124 | 0.200 |
Why?
|
Menopause | 3 | 2008 | 1640 | 0.200 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 25942 | 0.200 |
Why?
|
Reproductive Techniques | 1 | 2001 | 41 | 0.190 |
Why?
|
Alcohol Drinking | 5 | 2012 | 4013 | 0.190 |
Why?
|
Gamete Intrafallopian Transfer | 1 | 2001 | 27 | 0.190 |
Why?
|
Metacarpus | 1 | 2001 | 36 | 0.190 |
Why?
|
Insemination | 1 | 2021 | 18 | 0.190 |
Why?
|
Middle Aged | 34 | 2024 | 220352 | 0.190 |
Why?
|
Menstruation | 2 | 2017 | 307 | 0.190 |
Why?
|
Education, Medical | 1 | 2013 | 1727 | 0.190 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3602 | 0.190 |
Why?
|
Insurance | 1 | 2022 | 114 | 0.180 |
Why?
|
Sterilization Reversal | 1 | 2020 | 3 | 0.180 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2020 | 44 | 0.180 |
Why?
|
Counseling | 2 | 2018 | 1548 | 0.180 |
Why?
|
Fertilization | 3 | 2010 | 197 | 0.180 |
Why?
|
Erectile Dysfunction | 1 | 2023 | 452 | 0.170 |
Why?
|
Chromosome Segregation | 1 | 2001 | 233 | 0.170 |
Why?
|
Th2 Cells | 1 | 2005 | 1047 | 0.170 |
Why?
|
Sterilization, Tubal | 1 | 2020 | 80 | 0.170 |
Why?
|
Zygote | 1 | 2000 | 115 | 0.170 |
Why?
|
Infant, Newborn | 9 | 2023 | 26181 | 0.170 |
Why?
|
Treatment Outcome | 17 | 2022 | 65017 | 0.170 |
Why?
|
Administration, Intravaginal | 2 | 2018 | 151 | 0.170 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2012 | 2003 | 0.170 |
Why?
|
Societies, Medical | 1 | 2011 | 3905 | 0.160 |
Why?
|
United States | 15 | 2022 | 72461 | 0.160 |
Why?
|
Progestins | 2 | 2018 | 302 | 0.160 |
Why?
|
Embryonic Development | 5 | 2017 | 716 | 0.160 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2017 | 255 | 0.160 |
Why?
|
Family Planning Services | 1 | 2022 | 265 | 0.160 |
Why?
|
Ovarian Neoplasms | 2 | 2015 | 4878 | 0.160 |
Why?
|
Logistic Models | 5 | 2018 | 13314 | 0.150 |
Why?
|
Odds Ratio | 5 | 2018 | 9716 | 0.150 |
Why?
|
Reproductive Rights | 1 | 2018 | 30 | 0.150 |
Why?
|
Informed Consent | 1 | 2024 | 1005 | 0.150 |
Why?
|
Luteinizing Hormone | 1 | 2020 | 820 | 0.150 |
Why?
|
Estrogens | 6 | 2001 | 1520 | 0.150 |
Why?
|
Intergenerational Relations | 1 | 2017 | 68 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1959 | 0.140 |
Why?
|
Gravidity | 1 | 2017 | 50 | 0.140 |
Why?
|
Marital Status | 1 | 2019 | 433 | 0.140 |
Why?
|
Vitrification | 1 | 2017 | 51 | 0.140 |
Why?
|
Single-Blind Method | 2 | 2018 | 1578 | 0.140 |
Why?
|
Menotropins | 1 | 1996 | 41 | 0.140 |
Why?
|
Menstrual Cycle | 2 | 2011 | 536 | 0.140 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 95 | 0.140 |
Why?
|
Injections, Intramuscular | 3 | 2014 | 553 | 0.140 |
Why?
|
Cohort Studies | 13 | 2022 | 41335 | 0.140 |
Why?
|
Anastomosis, Surgical | 1 | 2020 | 983 | 0.140 |
Why?
|
Case-Control Studies | 9 | 2024 | 22053 | 0.140 |
Why?
|
Testosterone | 3 | 2020 | 2470 | 0.130 |
Why?
|
Biomimetics | 1 | 2017 | 173 | 0.130 |
Why?
|
Down-Regulation | 1 | 2023 | 2913 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3529 | 0.130 |
Why?
|
Contraceptive Agents, Female | 1 | 2017 | 118 | 0.130 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2017 | 177 | 0.130 |
Why?
|
Bone Marrow Diseases | 1 | 2017 | 232 | 0.130 |
Why?
|
Anemia, Aplastic | 1 | 2017 | 228 | 0.130 |
Why?
|
BRCA1 Protein | 2 | 2022 | 1147 | 0.120 |
Why?
|
Biological Assay | 1 | 2018 | 630 | 0.120 |
Why?
|
Hematologic Neoplasms | 1 | 2007 | 1895 | 0.120 |
Why?
|
Kidney Failure, Chronic | 2 | 1998 | 2471 | 0.120 |
Why?
|
Models, Genetic | 3 | 2001 | 3442 | 0.120 |
Why?
|
Administration, Cutaneous | 5 | 2000 | 713 | 0.120 |
Why?
|
Quality Control | 2 | 2015 | 828 | 0.120 |
Why?
|
Risk Factors | 15 | 2019 | 74359 | 0.120 |
Why?
|
Prenatal Care | 1 | 2022 | 1129 | 0.120 |
Why?
|
Osteoporosis | 2 | 2001 | 1600 | 0.120 |
Why?
|
Climacteric | 1 | 1994 | 57 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1764 | 0.120 |
Why?
|
Ovulation | 2 | 2009 | 181 | 0.120 |
Why?
|
Physician-Patient Relations | 2 | 2014 | 3242 | 0.120 |
Why?
|
Cross-Over Studies | 6 | 2000 | 2061 | 0.120 |
Why?
|
Drug Administration Schedule | 3 | 2018 | 4899 | 0.110 |
Why?
|
Gene Frequency | 1 | 2001 | 3615 | 0.110 |
Why?
|
Religion | 1 | 2017 | 376 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1229 | 0.110 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15840 | 0.110 |
Why?
|
Skinfold Thickness | 1 | 2014 | 158 | 0.110 |
Why?
|
Gestational Age | 2 | 2020 | 3565 | 0.110 |
Why?
|
Cannabis | 1 | 2020 | 436 | 0.110 |
Why?
|
Diabetes, Gestational | 1 | 2023 | 1242 | 0.110 |
Why?
|
Family Characteristics | 1 | 2019 | 1001 | 0.110 |
Why?
|
Leiomyoma | 2 | 2001 | 654 | 0.110 |
Why?
|
Sex Factors | 2 | 2019 | 10547 | 0.110 |
Why?
|
Pregnancy Complications | 2 | 2018 | 2942 | 0.110 |
Why?
|
Lipoproteins | 1 | 1998 | 882 | 0.110 |
Why?
|
Health Benefit Plans, Employee | 1 | 2016 | 333 | 0.110 |
Why?
|
Luteal Cells | 1 | 2013 | 19 | 0.110 |
Why?
|
Birth Weight | 2 | 2023 | 2097 | 0.110 |
Why?
|
Living Donors | 1 | 2017 | 636 | 0.110 |
Why?
|
Aged | 13 | 2019 | 169152 | 0.110 |
Why?
|
Hematoma | 1 | 2018 | 769 | 0.110 |
Why?
|
Time Factors | 8 | 2019 | 40165 | 0.100 |
Why?
|
Comparative Genomic Hybridization | 1 | 2014 | 473 | 0.100 |
Why?
|
Body Weight | 2 | 2006 | 4611 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 11712 | 0.100 |
Why?
|
Injections, Subcutaneous | 1 | 2014 | 680 | 0.100 |
Why?
|
Morula | 1 | 2012 | 11 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 10827 | 0.100 |
Why?
|
Gynecologic Surgical Procedures | 2 | 2015 | 304 | 0.100 |
Why?
|
Ovariectomy | 4 | 2007 | 611 | 0.100 |
Why?
|
Statistics, Nonparametric | 4 | 2011 | 2852 | 0.100 |
Why?
|
Body Height | 1 | 1998 | 1570 | 0.100 |
Why?
|
Achievement | 1 | 2013 | 289 | 0.100 |
Why?
|
Prognosis | 5 | 2020 | 29658 | 0.100 |
Why?
|
Granulosa Cells | 1 | 2012 | 115 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1846 | 0.100 |
Why?
|
Health Literacy | 1 | 2017 | 440 | 0.100 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2005 | 3075 | 0.100 |
Why?
|
Prospective Studies | 11 | 2022 | 54303 | 0.100 |
Why?
|
Premature Birth | 1 | 2023 | 1771 | 0.100 |
Why?
|
Abdominal Cavity | 1 | 2011 | 34 | 0.090 |
Why?
|
Overweight | 2 | 2020 | 2421 | 0.090 |
Why?
|
Stillbirth | 1 | 2014 | 368 | 0.090 |
Why?
|
Probability | 1 | 2016 | 2475 | 0.090 |
Why?
|
Emergencies | 1 | 2017 | 1211 | 0.090 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 389 | 0.090 |
Why?
|
Tissue and Organ Harvesting | 2 | 2004 | 377 | 0.090 |
Why?
|
Robotics | 1 | 2018 | 874 | 0.090 |
Why?
|
Patient Rights | 1 | 2011 | 125 | 0.090 |
Why?
|
Weight Loss | 2 | 2019 | 2686 | 0.090 |
Why?
|
Inservice Training | 1 | 2013 | 375 | 0.090 |
Why?
|
Boston | 4 | 2011 | 9280 | 0.090 |
Why?
|
Medical Records | 2 | 2009 | 1407 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2821 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2362 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2017 | 2435 | 0.080 |
Why?
|
Uterine Neoplasms | 2 | 2001 | 1439 | 0.080 |
Why?
|
Decision Making | 2 | 2014 | 3925 | 0.080 |
Why?
|
Vagina | 2 | 2011 | 837 | 0.080 |
Why?
|
Incidence | 4 | 2020 | 21392 | 0.080 |
Why?
|
Child | 6 | 2023 | 79806 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1841 | 0.080 |
Why?
|
Anxiety | 3 | 2023 | 4538 | 0.080 |
Why?
|
Registries | 3 | 2022 | 8469 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2013 | 12159 | 0.080 |
Why?
|
Heart Rate, Fetal | 1 | 2009 | 75 | 0.080 |
Why?
|
Homeodomain Proteins | 2 | 2009 | 2414 | 0.080 |
Why?
|
Inhibins | 1 | 2009 | 209 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2608 | 0.080 |
Why?
|
Treatment Failure | 2 | 2011 | 2648 | 0.080 |
Why?
|
Cell Count | 2 | 2010 | 1835 | 0.080 |
Why?
|
Parity | 1 | 2012 | 925 | 0.080 |
Why?
|
Sex Ratio | 1 | 2008 | 107 | 0.080 |
Why?
|
Cell Division | 5 | 2006 | 4463 | 0.080 |
Why?
|
Biopsy | 3 | 2017 | 6771 | 0.080 |
Why?
|
Analysis of Variance | 3 | 2005 | 6238 | 0.080 |
Why?
|
Bone Density | 1 | 2001 | 3534 | 0.080 |
Why?
|
Risk Assessment | 3 | 2019 | 24123 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5508 | 0.070 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2506 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2018 | 1150 | 0.070 |
Why?
|
Cervix Uteri | 3 | 2004 | 582 | 0.070 |
Why?
|
Regression Analysis | 2 | 2009 | 6360 | 0.070 |
Why?
|
Receptors, Progesterone | 4 | 2012 | 1130 | 0.070 |
Why?
|
Transplantation Conditioning | 2 | 2021 | 1588 | 0.070 |
Why?
|
Folic Acid | 1 | 2014 | 1309 | 0.070 |
Why?
|
Fetal Heart | 1 | 2009 | 281 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2688 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2018 | 5201 | 0.070 |
Why?
|
Mammary Glands, Human | 1 | 2008 | 203 | 0.070 |
Why?
|
Infertility, Male | 1 | 2010 | 396 | 0.070 |
Why?
|
Family | 1 | 2017 | 3189 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2696 | 0.070 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 695 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 2 | 2020 | 701 | 0.070 |
Why?
|
Health Policy | 1 | 2018 | 2677 | 0.070 |
Why?
|
Educational Measurement | 1 | 2013 | 1248 | 0.070 |
Why?
|
Fetus | 1 | 2013 | 1859 | 0.070 |
Why?
|
Half-Life | 2 | 1998 | 652 | 0.060 |
Why?
|
Gonadotropins, Pituitary | 1 | 2005 | 69 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2010 | 1697 | 0.060 |
Why?
|
Pedigree | 4 | 2001 | 4578 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7806 | 0.060 |
Why?
|
Child of Impaired Parents | 1 | 2008 | 459 | 0.060 |
Why?
|
Glioma | 1 | 2020 | 3420 | 0.060 |
Why?
|
Radiotherapy | 1 | 2011 | 1504 | 0.060 |
Why?
|
HIV Infections | 1 | 2011 | 17165 | 0.060 |
Why?
|
Internet | 1 | 2017 | 3078 | 0.060 |
Why?
|
Child, Preschool | 3 | 2023 | 42063 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12531 | 0.060 |
Why?
|
Pilot Projects | 2 | 2017 | 8555 | 0.060 |
Why?
|
Coercion | 1 | 2024 | 69 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2013 | 1116 | 0.060 |
Why?
|
Bone and Bones | 2 | 2013 | 2560 | 0.060 |
Why?
|
Polymerase Chain Reaction | 5 | 2012 | 6068 | 0.060 |
Why?
|
Animals | 13 | 2023 | 167963 | 0.060 |
Why?
|
Depression | 3 | 2023 | 8044 | 0.060 |
Why?
|
Morphogenesis | 1 | 2007 | 740 | 0.050 |
Why?
|
Infant | 2 | 2023 | 36060 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3258 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2017 | 58995 | 0.050 |
Why?
|
Ultrasonography | 5 | 2013 | 5961 | 0.050 |
Why?
|
Donor Selection | 1 | 2024 | 228 | 0.050 |
Why?
|
Acupuncture Therapy | 1 | 2007 | 480 | 0.050 |
Why?
|
Laparoscopy | 3 | 2011 | 2147 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4446 | 0.050 |
Why?
|
Aging | 2 | 2017 | 8651 | 0.050 |
Why?
|
Sperm Motility | 1 | 2023 | 265 | 0.050 |
Why?
|
Attitude to Health | 1 | 2011 | 2029 | 0.050 |
Why?
|
Paclitaxel | 1 | 2010 | 1736 | 0.050 |
Why?
|
Glomerulonephritis | 1 | 2004 | 337 | 0.050 |
Why?
|
Receptors, Prolactin | 1 | 2001 | 16 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3315 | 0.050 |
Why?
|
Croatia | 1 | 2001 | 34 | 0.050 |
Why?
|
Diethylstilbestrol | 1 | 2001 | 88 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2013 | 1925 | 0.050 |
Why?
|
Trust | 1 | 2006 | 532 | 0.050 |
Why?
|
Russia | 2 | 1999 | 381 | 0.050 |
Why?
|
Mullerian Ducts | 1 | 2001 | 201 | 0.050 |
Why?
|
Testis | 1 | 2004 | 794 | 0.050 |
Why?
|
Endometrium | 3 | 2017 | 403 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 1262 | 0.040 |
Why?
|
Diploidy | 1 | 2000 | 132 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 1664 | 0.040 |
Why?
|
Th1 Cells | 1 | 2005 | 1032 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15789 | 0.040 |
Why?
|
Pregnancy, High-Risk | 1 | 2000 | 119 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2640 | 0.040 |
Why?
|
Twins, Monozygotic | 1 | 2001 | 469 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4938 | 0.040 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2005 | 546 | 0.040 |
Why?
|
Sperm Count | 1 | 2020 | 228 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2005 | 1557 | 0.040 |
Why?
|
Culture Media | 1 | 2021 | 900 | 0.040 |
Why?
|
Kyrgyzstan | 1 | 1998 | 3 | 0.040 |
Why?
|
Blastomeres | 1 | 1998 | 29 | 0.040 |
Why?
|
Anesthesia, Intravenous | 1 | 2019 | 131 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3707 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2004 | 2221 | 0.040 |
Why?
|
Cicatrix | 1 | 2004 | 782 | 0.040 |
Why?
|
Semen Analysis | 1 | 2020 | 234 | 0.040 |
Why?
|
Lactation Disorders | 1 | 2017 | 14 | 0.040 |
Why?
|
Parthenogenesis | 1 | 2017 | 30 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2022 | 798 | 0.040 |
Why?
|
Cannabinoids | 1 | 2020 | 173 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 1995 | 6315 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2012 | 15289 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9185 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4783 | 0.040 |
Why?
|
Genital Diseases, Female | 1 | 1998 | 191 | 0.040 |
Why?
|
Cytokines | 2 | 2018 | 7343 | 0.040 |
Why?
|
Anesthesia, General | 1 | 2004 | 1166 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3610 | 0.040 |
Why?
|
Absorption | 1 | 1996 | 243 | 0.030 |
Why?
|
Abortifacient Agents, Nonsteroidal | 1 | 2017 | 64 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 193 | 0.030 |
Why?
|
Intraoperative Complications | 2 | 2000 | 1186 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2017 | 573 | 0.030 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1998 | 275 | 0.030 |
Why?
|
Pregnancy, Animal | 1 | 1996 | 124 | 0.030 |
Why?
|
Medroxyprogesterone Acetate | 1 | 1996 | 155 | 0.030 |
Why?
|
Suction | 1 | 2017 | 263 | 0.030 |
Why?
|
Israel | 1 | 1998 | 722 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2798 | 0.030 |
Why?
|
Mexico | 1 | 1998 | 760 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 1999 | 724 | 0.030 |
Why?
|
Anesthetics, Intravenous | 1 | 2019 | 397 | 0.030 |
Why?
|
Fentanyl | 1 | 2019 | 434 | 0.030 |
Why?
|
Fetal Death | 1 | 2017 | 434 | 0.030 |
Why?
|
Gene Expression | 3 | 2000 | 7588 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1677 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2007 | 3696 | 0.030 |
Why?
|
Genetic Variation | 2 | 2019 | 6551 | 0.030 |
Why?
|
Ergotamines | 1 | 1994 | 4 | 0.030 |
Why?
|
Belladonna Alkaloids | 1 | 1994 | 4 | 0.030 |
Why?
|
Methysergide | 1 | 1994 | 28 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2001 | 7593 | 0.030 |
Why?
|
Catheterization | 1 | 2000 | 1432 | 0.030 |
Why?
|
Panax | 1 | 1994 | 28 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10551 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10344 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11152 | 0.030 |
Why?
|
Age of Onset | 1 | 2001 | 3301 | 0.030 |
Why?
|
Reoperation | 1 | 2004 | 4291 | 0.030 |
Why?
|
Colorado | 1 | 2014 | 164 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1995 | 522 | 0.030 |
Why?
|
Double-Blind Method | 3 | 2000 | 12427 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2001 | 932 | 0.030 |
Why?
|
Plants, Medicinal | 1 | 1994 | 166 | 0.030 |
Why?
|
Genotype | 3 | 2008 | 12960 | 0.030 |
Why?
|
Phenobarbital | 1 | 1994 | 189 | 0.030 |
Why?
|
Directive Counseling | 1 | 2015 | 171 | 0.030 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1994 | 178 | 0.030 |
Why?
|
Serum Albumin | 1 | 1996 | 674 | 0.030 |
Why?
|
Mice, Inbred BALB C | 4 | 2007 | 6216 | 0.030 |
Why?
|
Sexual Partners | 1 | 2018 | 753 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5797 | 0.030 |
Why?
|
Genetics, Population | 1 | 1998 | 930 | 0.030 |
Why?
|
Cadaver | 1 | 2017 | 1345 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2008 | 11903 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2004 | 1570 | 0.030 |
Why?
|
RNA | 2 | 2017 | 2722 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2001 | 1365 | 0.030 |
Why?
|
Propofol | 1 | 2019 | 608 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8552 | 0.030 |
Why?
|
Smoking | 2 | 2012 | 9073 | 0.030 |
Why?
|
Twins | 1 | 1994 | 339 | 0.030 |
Why?
|
Receptors, LH | 1 | 2012 | 18 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1180 | 0.030 |
Why?
|
Receptors, Prostaglandin E, EP3 Subtype | 1 | 2012 | 23 | 0.030 |
Why?
|
Tissue Banks | 1 | 2013 | 184 | 0.030 |
Why?
|
Telomerase | 1 | 2017 | 746 | 0.030 |
Why?
|
Recurrence | 1 | 2004 | 8482 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 1998 | 1817 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39261 | 0.020 |
Why?
|
Clone Cells | 1 | 1995 | 1660 | 0.020 |
Why?
|
Genes, BRCA2 | 1 | 2015 | 603 | 0.020 |
Why?
|
Women's Health | 2 | 2014 | 2056 | 0.020 |
Why?
|
Mice | 8 | 2023 | 81208 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2023 | 2890 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4166 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2101 | 0.020 |
Why?
|
Injections | 1 | 1994 | 830 | 0.020 |
Why?
|
Blood Pressure | 2 | 1999 | 8525 | 0.020 |
Why?
|
Genes, BRCA1 | 1 | 2015 | 765 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8056 | 0.020 |
Why?
|
Cricetulus | 1 | 2012 | 815 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2000 | 2086 | 0.020 |
Why?
|
Placebos | 1 | 1995 | 1668 | 0.020 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2011 | 116 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2001 | 2629 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1502 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12965 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 877 | 0.020 |
Why?
|
RNA, Messenger | 4 | 2001 | 12766 | 0.020 |
Why?
|
Random Allocation | 1 | 1995 | 2394 | 0.020 |
Why?
|
CHO Cells | 1 | 2012 | 1389 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17790 | 0.020 |
Why?
|
Fragile X Syndrome | 1 | 2011 | 116 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9585 | 0.020 |
Why?
|
Glycosylation | 1 | 2012 | 1096 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2011 | 783 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1881 | 0.020 |
Why?
|
Siblings | 1 | 2013 | 824 | 0.020 |
Why?
|
Cricetinae | 1 | 2012 | 2427 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2010 | 402 | 0.020 |
Why?
|
Research Design | 2 | 2020 | 6180 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 747 | 0.020 |
Why?
|
Renal Dialysis | 1 | 1998 | 1801 | 0.020 |
Why?
|
Menarche | 1 | 2012 | 529 | 0.020 |
Why?
|
Postoperative Complications | 3 | 2019 | 15697 | 0.020 |
Why?
|
Cell Size | 1 | 2010 | 624 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 1109 | 0.020 |
Why?
|
Milk, Human | 1 | 2012 | 483 | 0.020 |
Why?
|
Drug Combinations | 1 | 1994 | 2025 | 0.020 |
Why?
|
Motivation | 1 | 2017 | 1993 | 0.020 |
Why?
|
Organ Culture Techniques | 2 | 2000 | 796 | 0.020 |
Why?
|
DNA Damage | 1 | 2017 | 2442 | 0.020 |
Why?
|
Abortion, Induced | 1 | 2013 | 460 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1995 | 6131 | 0.020 |
Why?
|
Kinetics | 1 | 1995 | 6377 | 0.020 |
Why?
|
Anthropometry | 1 | 2012 | 1348 | 0.020 |
Why?
|
Electroacupuncture | 1 | 2007 | 66 | 0.020 |
Why?
|
Androgens | 1 | 1994 | 1291 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2009 | 535 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2014 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 1035 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 672 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2017 | 2781 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2012 | 10446 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5039 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2007 | 349 | 0.020 |
Why?
|
Peer Review | 1 | 2007 | 218 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2000 | 1900 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16939 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2819 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2315 | 0.010 |
Why?
|
Cell Cycle | 1 | 2012 | 2934 | 0.010 |
Why?
|
Epithelial Cells | 2 | 2009 | 3663 | 0.010 |
Why?
|
Stromal Cells | 2 | 2001 | 1326 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3607 | 0.010 |
Why?
|
Infusion Pumps | 1 | 2004 | 163 | 0.010 |
Why?
|
Ovum | 1 | 2004 | 187 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 18957 | 0.010 |
Why?
|
Health Surveys | 1 | 2013 | 4063 | 0.010 |
Why?
|
Epoprostenol | 1 | 2004 | 248 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14660 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2004 | 472 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2007 | 1376 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2006 | 579 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5075 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3711 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1096 | 0.010 |
Why?
|
Calcium | 1 | 1995 | 5725 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2014 | 3392 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5781 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2754 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 2006 | 859 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3618 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8803 | 0.010 |
Why?
|
Biomedical Research | 1 | 2016 | 3426 | 0.010 |
Why?
|
Gels | 1 | 2001 | 419 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9335 | 0.010 |
Why?
|
Clomiphene | 1 | 2000 | 71 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4122 | 0.010 |
Why?
|
Life Style | 1 | 2012 | 3896 | 0.010 |
Why?
|
Turkmenistan | 1 | 1999 | 3 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12626 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3442 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2049 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2418 | 0.010 |
Why?
|
Computational Biology | 1 | 2012 | 3505 | 0.010 |
Why?
|
Hypertension | 1 | 1999 | 8594 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22023 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12808 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2893 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1999 | 866 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36290 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29932 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12446 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4090 | 0.010 |
Why?
|
Quantitative Trait, Heritable | 1 | 2000 | 540 | 0.010 |
Why?
|
Exercise | 1 | 1994 | 5787 | 0.010 |
Why?
|
Drug Synergism | 1 | 2001 | 1754 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2008 | 11481 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 224 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2000 | 1098 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1999 | 987 | 0.010 |
Why?
|
Diet | 1 | 2014 | 8010 | 0.010 |
Why?
|
Laparotomy | 1 | 1998 | 465 | 0.010 |
Why?
|
Epithelium | 1 | 2000 | 1605 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15620 | 0.010 |
Why?
|
Signal Transduction | 2 | 2009 | 23376 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7850 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2004 | 2061 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20509 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 15687 | 0.010 |
Why?
|
Proteins | 1 | 2008 | 6029 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 1998 | 15757 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9411 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16546 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2001 | 3604 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2000 | 6498 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2001 | 3301 | 0.010 |
Why?
|
Reference Values | 1 | 1995 | 4925 | 0.000 |
Why?
|
Mental Health | 1 | 2000 | 3213 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8158 | 0.000 |
Why?
|
DNA | 1 | 1999 | 7233 | 0.000 |
Why?
|
Quality of Life | 1 | 2007 | 13308 | 0.000 |
Why?
|
Thyroid (USP) | 1 | 1962 | 3 | 0.000 |
Why?
|
Rats | 1 | 1996 | 23711 | 0.000 |
Why?
|
Thyroid Hormones | 1 | 1962 | 403 | 0.000 |
Why?
|
Hospitalization | 1 | 1998 | 10790 | 0.000 |
Why?
|
Thyroid Gland | 1 | 1962 | 1168 | 0.000 |
Why?
|